Neuropsychological aspects of coinfection with HIV and hepatitis C virus

Clinical Infectious Diseases

Volumn 41, Issue 1 SUPPL., 2005, Pages

  Hilsabeck, Robin C ^a   Castellon, Steven A ^b,c   Hinkin, Charles H ^b,c  

^a SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; METHAMPHETAMINE; N ACETYLASPARTIC ACID; RECOMBINANT INTERFERON; RIBAVIRIN;

ANXIETY; CANNABIS ADDICTION; CLINICAL FEATURE; COCAINE DEPENDENCE; COGNITIVE DEFECT; DEPRESSION; DISEASE SEVERITY; DRUG USE; FATIGUE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MANIA; MENTAL DISEASE; MORBIDITY; MORTALITY; NEUROPSYCHIATRY; NEUROPSYCHOLOGY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SUICIDE; SUPERINFECTION; VIRUS TRANSMISSION;

COGNITION; COGNITION DISORDERS; FRONTAL LOBE; HEPATITIS C; HIV INFECTIONS; HUMANS; MENTAL DISORDERS; PSYCHOMOTOR PERFORMANCE; SUBSTANCE-RELATED DISORDERS;

EID: 20844451018     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/429494     Document Type: Review

References (48)

1. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345:41-52.
2. Verucchi G, Calza L, Manfredi R, Chiodo F. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management. Infection 2004; 32:33-46.
3. Rosenberg SD, Swanson JW, Wolford G, et al. The Five-Site Health and Risk Study of blood-borne infections among persons with severe mental illness. Psychiatr Serv 2003; 54:827-35.
4. Dinwiddie SH, Shicker L, Newman T. Prevalence of hepatitis C among psychiatric patients in the public sector. Am J Psychiatry 2003; 160: 172-4.
5. Hilsabeck RC, Perry W, Hassanein TI. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology 2002; 35:440-6.
6. Hilsabeck RC, Hassanein TI, Carlson MD, Ziegler EA, Perry W. Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. J Int Neuropsychol Soc 2003; 9:847-54.
7. Chang L, Ernst T, Leonido-Yee M, Walot I, Singer E. Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Neurology 1999; 52:100-8.
8. Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD. Evidence for a cerebral effect of the hepatitis C virus. Lancet 2001; 358:38-9.
9. Forton DM, Thomas HC, Murphy CA, et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002; 35:433-9.
10. Hinkin CH, Castellon SA, van Gorp WG, Satz P. Neuropsychological features of HIV infection. In: van Gorp WG, Buckingham SL, eds. A mental health practitioner's guide to the neuropsychiatric complications of HIV/AIDS. New York: Oxford University Press, 1997:1-41.
11. Becker JT, Salthouse TA. Neuropsychological test performance in the acquired immunodeficiency syndrome: independent effects of diagnostic group on functioning. J Int Neuropsychol Soc 1999; 5:41-7.
12. Hinkin CH, Castellon SA, Hardy DJ, Granholm E, Siegle G. Computerized and traditional Stroop task dysfunction in HIV-1 infection. Neuropsychology 1999; 13:111-21.
13. Hinkin CH, Castellon SA, Hardy DJ. Dual task performance in HIV-1 infection. J Clin Exp Neuropsychol 2000; 22:16-24.
14. Martin EM, Pitrak DL, Pursell KJ, Mullane KM, Novak RM. Delayed recognition memory span in HIV-1 infection. J Int Neuropsychol Soc 1995; 1:575-80.
15. Rabkin JD, Fernando SJ, Jacobsberg LB, et al. Prevalence of axis I disorders in an AIDS cohort: a cross-sectional controlled study. Compr Psychiatry 1997; 38:146-54.
16. Castellon SA, Hinkin CH, Wood S, Yarema K. Apathy, depression and cognitive performance in HIV-1 infection. J Neuropsychiatry Clin Neurosci 1998; 10:320-9.
17. Castellon SA, Hinkin CH, Myers HF. Neuropsychiatric disturbance is associated with executive dysfunction in HIV-1 infection. J Int Neuropsychol Soc 2000; 6:336-47.
18. Hestad K, McArthur JH, Dal Pan GJ, et al. Regional brain atrophy in HIV-1 infection: association with specific neuropsychological test performance. Acta Neurol Scand 1993; 88:112-8.
19. Hinkin CH, van Gorp WG, Mandelkern MA, et al. Cerebral metabolic change in patients with AIDS: report of a six-month follow-up using positron-emission tomography. J Neuropsychiatry Clin Neurosci 1995; 7:180-7.
20. Navia BA, Cho ES, Petito C, Price R. The AIDS dementia complex. II. Neuropathology. Ann Neurol 1986; 19:525-35.
21. White DA, Heaton RK, Monsch AU. Neuropsychological studies of asymptomatic human immunodeficiency virus-type-1 infected individuals. The HNRC Group. J Int Neuropsychol Soc 1995; 1:304-15.
22. Taylor MJ, Letendre SL, Schweinsburg BC, et al. Hepatitis C virus infection is associated with reduced white matter N-acetylaspartate in abstinent methamphetamine users. J Int Neuropsychol Soc 2004; 10: 110-3.
23. Forton DM, Taylor-Robinson SD, Thomas HC. Reduced quality of life in hepatitis C-is it all in the head? J Hepatol 2002; 36:435-8.
24. Afonso AM, Jiang J, Penin F, et al. Non-random distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets. J Virol 1999; 73:9213-21.
25. Kramer L, Bauer E, Funk G, et al. Subclinical impairment of brain function in chronic hepatitis C infection. J Hepatol 2002; 37:349-54.
26. Kraus MR, Schäfer A, Csef H, Scheurlen M, Faller H. Emotional state, coping styles, and somatic variables in patients with chronic hepatitis C. Psychosomatics 2000; 41:377-84.
27. Fontana RJ, Hussain KB, Schwartz SM, Moyer CA, Su GL, Lok ASF. Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. J Hepatol 2002; 36:401-7.
28. Dieperink E, Willenbring M, Ho SB. Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: a review. Am J Psychiatry 2000; 157:867-76.
29. El-Serag HB, Kunik M, Richardson P, Rabeneck L. Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology 2002; 123: 476-82.
30. Yovtcheva SP, Aly Rifai M, Moles JK, Van Der Linden BJ. Psychiatric comorbidity among hepatitis C-positive patients. Psychosomatics 2001; 42:411-5.
31. Barkuizen A, Rosen HR, Wolf S, et al. Musculoskeletal pain and fatigue are associated with chronic hepatitis C. Am J Gastroenterol 1999; 94: 1355-60.
32. Coverdale JH, Turbott SH. Risk behaviors for sexually transmitted infections among men with mental disorders. Psychiatr Serv 2000; 51: 234-8.
33. Kendall JC, Sherman MF. Psychiatric symptoms in polysubstance abusers: relationship to race, sex, and age. Addict Behav 1995; 20:685-90.
34. Kronfol Z, Remick DG. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 2000; 157:683-94.
35. Gochee PA, Powell EE, Purdie DM, et al. Association between apolipoprotein E ε4 and neuropsychiatric symptoms during interferon-α treatment for chronic hepatitis C. Psychosomatics 2004; 45:49-57.
36. Letendre S, Cherner M, Ellis RJ, et al. Individuals co-infected with hepatitis C (HCV) and HIV are more cognitively impaired than those infected with either virus alone [abstract]. J Neurovirol 2002; 8(Suppl 1):S14.
37. Martin EM, Novak RM, Fendrich M, et al. Stroop performance in drug users classified by HIV and hepatitis C virus serostatus. J Int Neuropsychol Soc 2004; 10:298-300.
38. von Giesen H, Heintges T, Abbasi-Boroudjeni N, et al. Psychomotor slowing in hepatitis C and HIV infection. J Acquir Immune Defic Syndr 2004; 35:131-7.
39. Ryan, EL, Morgello S, Isaacs K, et al. Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology 2004; 62:957-62.
40. Perry W, Carlson M, Barakat F, Hilsabeck R, Hassanein T. Neuropsychological test performance in patients coinfected with HCV and HIV AIDS (in press).
41. Hinkin CH, Aronow HA, Hilsabeck RC, et al. Psychiatric and cognitive concomitants of HIV and HCV co-infection. In: Program and abstracts of the National Institute on Drug Abuse (NIDA) symposium on issues in the medical management of HIV/HCV co-infection in IDUs (Washington, DC). Bethesda, MD: NIDA, 2004:8.
42. Laskus T, Radkowski M, Jablonska J, et al. Human immunodeficiency virus facilitates infection/replication of hepatitis C virus in native human macrophages. Blood 2004; 103:3854-9.
43. Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology 1999; 30:1054-8.
44. Grassi L, Satriano J, Serra A, et al. Emotional stress, psychosocial variables and coping associated with hepatitis C virus and human immunodeficiency virus infections in intravenous drug users. Psychother Psychosom 2002; 71:342-9.
45. Hilsabeck RC, Carlson MD, Ziegler EA, et al. Comparison of psychiatric symptoms in patients with hepatitis C, human immunodeficiency virus, and co-infection [abstract]. J Neuropsychiatry Clin Neurosci 2003; 15: 281.
46. Hilsabeck RC, Hassanein TI, Ziegler EA, Carlson MD, Perry W. Effect of interferon-α on cognitive functioning in patients with chronic hepatitis C. J Int Neuropsychol Soc 2005; 11:16-22.
47. Selnes OA, McArthur JC, Royal W, et al. HIV-1 infection and intravenous drug use: longitudinal neuropsychological evaluation of asymptomatic subjects. Neurology 1992; 42:1924-30.
48. Soriano V, Puoti, M, Sulkowski M, et al. Care of patients with hepatitis C and HIV co-infection. AIDS 2004; 18:1-12.